In rats, in contrast with human subjects who develop megaloblastic anaemia due to vitamin B 12 deficiency, haematological abnormalities with anaemia were not observed under normoxic conditions even though plasma vitamin B 12 concentration was reduced to , 15 % of a normal concentration by depleting dietary vitamin B 12 . To elucidate whether erythropoiesis was affected by vitamin B 12 deficiency in rats, these vitamin B 12 -deficient rats were exposed to hypoxia (10·5 % O 2 ) to stimulate erythropoiesis. In the vitamin B 12 -sufficient control rats, erythrocyte count was significantly (P,0·05) increased 1 week after starting the hypoxic exposure. However, the hypoxia-induced erythropoiesis was affected by vitamin B 12 deficiency, and no significant increase in the erythrocyte count was observed even after 6-week exposure to hypoxia in the vitamin B 12 -deficient rats. In the vitamin B 12 -deficient rats in hypoxia, erythrocytes became abnormally enlarged, and haemoglobin concentration in peripheral blood was increased in proportion to the increase of mean corpuscular volume. However, the level of the increase in the haemoglobin concentration was significantly (P, 0·05) lower in the vitamin B 12 -deficient rats compared with that in the -sufficient controls. In addition, in the vitamin B 12 -deficient rats, in contrast to the -sufficient rats, serum erythropoietin concentration was not normalized even after 6-week exposure to hypoxia. These results indicate that a megaloblastic anaemia-like symptom is induced when the vitamin B 12 -deficient rats are exposed to hypoxia.
In experimental animals, in contrast with human subjects, it is very difficult to induce megaloblastic anaemia by depleting dietary vitamin B 12 (England & Linnell, 1979) . For example, in fruit bats (Rousettus aegyptiacus ), Green et al. (1975) have reported that haematological abnormalities, except for a reduction of leucocyte count, are not induced even if dietary vitamin B 12 is depleted for 47 weeks, although clear neurological abnormalities are observed. Thus, megaloblastic anaemia due to vitamin B 12 deficiency seems to be unique to man. It may be that man is more reliant on the de novo synthesis of thymidylate, and less able to salvage it from DNA breakdown, than other species (Bender, 1992) . In addition, since folate is sufficiently provided in the diet of most animals used as a model of vitamin B 12 deficiency, anaemia might be masked in these animals (Stabler, 2000) ; details, however, remain obscure.
In mammals, hypoxia causes erythropoiesis to maintain an adequate level of O 2 in tissues. This is controlled by erythropoietin (Epo) produced in the kidneys (Jelkman, 1992; Bunn & Poyton, 1996) . Epo operates on erythroid progenitor cells and enables them to proliferate into functioning erythrocytes (ERC).
To elucidate whether erythropoiesis is affected by vitamin B 12 deficiency in mammals other than man, we have exposed rats with dietary vitamin B 12 deficiency to hypoxia to stimulate erythropoiesis. In the present paper, we report that the hypoxia-induced erythropoiesis is affected in rats when plasma vitamin B 12 concentration is reduced to , 15 % of a normal level, even though apparent haematological abnormalities are not induced in normoxia. In addition, it is also reported that a megaloblastic anaemialike symptom appears in the vitamin B 12 -deficient rats under hypoxic conditions.
Materials and methods
Male weanling rats (3 weeks old), born to 14-week-old parent rats that had been fed a vitamin B 12 -deficient diet for 8 weeks, were used. The parent rats were obtained from Kiwa Laboratory Animals (Wakayama, Japan). The vitamin B 12 -deficient diet contained (g/kg): defatted soyabean (about 500 g crude protein ðN £ 6·25Þ and 500 g carbohydrate; donated by Fuji Oil, Osaka, Japan) 400, glucose 438, soyabean oil 100, mineral mixture 50, vitamin B 12 -free vitamin mixture 5, choline chloride 2. The mineral and vitamin mixtures were prepared as described previously (Watanabe et al. 1991) . Folic acid (5 mg/kg) was included in the diet. The animals used were maintained in accordance with the guidelines of the National Research Council (1985) .
The weanling rats were housed individually in wire-bottomed cages at controlled temperature ð22^28CÞ; humidity ð55^5 %Þ and lighting (lights on 08.00-20.00 hours), and fed the vitamin B 12 -deficient or -sufficient diet. The vitamin B 12 -sufficient diet was identical to the -deficient one, except that 25 mg cyanocobalamin/kg was included. After being maintained for 17 weeks from weanling on the experimental diet, these rats (20 weeks old) were exposed to hypoxia (10·5 % O 2 ) in an ambient chamber for an additional 6 weeks. Hypoxic conditions were introduced by flowing a mixed gas (O 2 -N 2 (10·5:89·5, v/v)), produced by Pana O 2 apparatus (donated by Matsushita Electric, Osaka, Japan), into the chamber, and the O 2 concentration in the chamber was maintained by monitoring with an O 2 monitor during the exposure (Yamaji et al. 1996) .
During the hypoxic exposure, blood samples were obtained from tail vein, and ERC count, mean corpuscular volume (MCV) and haemoglobin (Hb) concentration were measured with an automatic blood corpuscle count apparatus (Sysmex K-1000, Toua Iyou Electric, Kobe, Japan). At the end of the 6-week hypoxic exposure, blood was collected from inferior vena cava (under diethyl ether anaesthesia). Vitamin B 12 and methylmalonic acid (MMA) were determined in plasma according to the methods of Ebara et al. (2001) and Toyoshima et al. (1996) . Serum Epo concentration was determined by a radioimmunoassay method using a commercial kit (Recombigen Epo Kit, IatRon Laboratory, Ichikawa, Japan) according to the manufacturer's instruction.
Statistical analyses
Statistical analyses were performed with GB-Stat 5.4 (Dynamic Microsystems, Silver Spring, MD, USA). Haematological variables were compared between the vitamin B 12 -sufficient and -deficient groups during the hypoxic exposure by two-way ANOVA for repeated measures, and post-hoc analyses were done by Newman -Keuls test. Change in Epo concentration during the hypoxic exposure was compared between the vitamin B 12 -sufficient anddeficient groups by two-way ANOVA followed by Newman -Keuls test. Data on vitamin B 12 and MMA were analysed by one-way ANOVA followed by Scheffé post-hoc test. All results are presented as mean values with their standard errors, and statistical significance is defined as P, 0·05.
Results
When weanling rats (3 weeks old) were fed a vitamin B 12 -deficient diet for 17 weeks, plasma vitamin B 12 concentration was reduced to 0·15 (SE 0·011) nM (n 5), which was 13·5 % of the level of the vitamin B 12 -sufficient control rats (1·11 (SE 0·015) nM (n 5)). In addition, plasma MMA level was abnormally elevated in the vitamin B 12 -deficient rats (0·96 (SE 0·126) mM (n 5)), whereas it was undetectable in the -sufficient rats.
Under normoxic conditions, no statistically significant changes in ERC count, MCV and Hb concentration in peripheral blood were induced in the vitamin B 12 -deficient rats at 20 weeks of age (Fig. 1) . These rats were exposed to hypoxia (10·5 % O 2 ) for 6 weeks, and changes in these haematological variables were examined. In the vitamin B 12 -sufficient control rats, about 25 % of increase (P, 0·05) in the ERC count was observed 1 week after starting the exposure, and the significantly higher level was maintained thereafter. In contrast, in the vitamin B 12 -deficient rats, no significant increase was induced in the ERC count even after the 6-week exposure to hypoxia. The hypoxic exposure caused elevation in MCV in both the vitamin B 12 -sufficient and -deficient groups, but the extent was significantly (P, 0·05) greater in the -deficient rats. A significant elevation in the Hb concentration was observed in the vitamin B 12 -deficient rats as well as the -sufficient controls. However, the Hb concentration in the vitamin B 12 -deficient rats was significantly (P, 0·05) lower than that in the -sufficient controls at any time points examined during the hypoxic exposure. The plasma vitamin B 12 level in the vitamin B 12 -deficient rats was not significantly decreased by the hypoxic exposure for 6 weeks (0·15 (SE 0·011) (n 5) v. 0·14 (SE 0·031) (n 5) nM). In addition, no significant change in the plasma MMA concentration was observed after the 6-week exposure to hypoxia (0·96 (SE 0·127) (n 5) v. 0·89 (SE 0·090) (n 5) mM). These results suggest that vitamin B 12 deficiency was not made more severe by the 6-week exposure to hypoxia. Serum Epo concentration was followed during the hypoxic exposure for 6 weeks (Table 1) . Before the exposure (in normoxia), the Epo concentration in the vitamin B 12 -deficient rats was not significantly different from that in the -sufficient controls. One day after starting the hypoxic exposure, Epo in serum was significantly (P, 0·05) elevated in both the vitamin B 12 -sufficient and -deficient groups. In the vitamin B 12 -sufficient group, the elevated Epo concentration returned to a normal level (normoxic level) in 1 week after starting the exposure.
However, in the vitamin B 12 -deficient rats, the Epo concentration remained at a significantly (P, 0·05) higher concentration compared with that in normoxia, throughout the 6-week exposure to hypoxia.
Discussion
Vitamin B 12 deficiency results in the inactivation of methylmalonyl-CoA mutase and methionine synthase, which require 5 0 -deoxyadenosyl-cobalamin and methylcobalamin respectively, as a coenzyme, and consequently MMA and homocysteine are abnormally increased in plasma and excreted into urine (Toyoshima et al. 1996; Stabler, 2000) . In human patients with severe vitamin B 12 deficiency, megaloblastic anaemia, in addition to neurological abnormalities, is often observed. The megaloblastic anaemia observed in vitamin B 12 -deficient patients is thought to result from the inactivation of methionine synthase, which leads to the impairment of folic acid metabolism closely related to thymidylate and purine biosynthesis (Shane, 1985 , Koury et al. 2000 . However, it has been reported that haematological abnormalities with anaemia do not appear in experimental animals, in contrast with human subjects, even under severe vitamin B 12 -deficient conditions in which neurological abnormalities are induced (Kark et al. 1974; Green et al. 1975; Crampton et al. 1979) .
Under our present experimental conditions, the plasma concentration of vitamin B 12 was reduced to 0·15 nM (, 15 % of that in the vitamin B 12 -sufficient controls) by depleting dietary vitamin B 12 in rats. In addition, as observed in our previous paper (Toyoshima et al. 1996) , the plasma MMA concentrations was abnormally raised in these rats. However, no statistically significant changes in the ERC count, MCV and Hb concentration in peripheral blood were observed in the vitamin B 12 -deficient rats (Fig. 1) . These results suggest that rats, as well as other experimental animals, do not develop megaloblastic anaemia due to vitamin B 12 deficiency under normoxic conditions.
When mammals are exposed to low O 2 conditions, Epo is produced in kidney and erythropoiesis is induced by the action of Epo to provide O 2 into tissues at an adequate level (Hill et al. 1987; Jelkman, 1992; Bunn & Poyton, 1996) . To examine the effect of vitamin B 12 deficiency on the hypoxia-induced erythropoiesis, these vitamin B 12 -deficient rats were exposed to 10·5 % O 2 conditions for 6 weeks. In the vitamin B 12 -sufficient control rats, a significant (P, 0·05) increase (about 25 %) in the ERC count was observed in 1 week after starting the exposure (Fig. 1) . However, the hypoxia-induced erythropoiesis was inhibited by vitamin B 12 deficiency, and the ERC count was not significantly increased even after the 6-week exposure to hypoxia in the vitamin B 12 -deficient group. It is thus reasonable to postulate that thymidylate and purine biosynthesis are affected under vitamin B 12 -deficient conditions in rats as well as human subjects, and the increase in the ERC count is inhibited due to the impairment of DNA synthesis in the deficient rats when exposed to hypoxia. MCV was increased, with concomitant increase in Hb content per ERC, in hypoxia (Hill et al. 1987) . The extent of the increase was significantly (P, 0·05) greater in the vitamin B 12 -deficient rats than the -sufficient rats. In addition, the Hb concentration in peripheral blood was increased in proportion to the increase in MCV in the deficient rats in hypoxia. Thus, in these rats, ERC become abnormally enlarged to increase Hb in peripheral blood as much as possible, since the hypoxia-induced erythropoiesis is inhibited under the vitamin B 12 -deficient conditions. However, the Hb concentration was significantly (P, 0·05) lower in the vitamin B 12 -deficient rats than the -sufficient controls at any time point examined during the 6-week exposure to hypoxia. These observations suggest that a megaloblastic anaemia-like symptom is induced in the vitamin B 12 -deficient rats when exposed to hypoxia. Carmel & MacPhee (1992) have observed that Epo in serum is abnormally increased in response to the reduction of the Hb concentration in peripheral blood in vitamin B 12 -deficient patients with anaemia. No significant difference was observed in the serum Epo concentration between the vitamin B 12 -sufficient and -deficient rats in normoxia ( Table 1 ), confirming that the -deficient rats do not have anaemia under the present conditions. It has been reported that a great increase in the serum Epo concentration is transiently induced in rats after exposure to low O 2 conditions (Tan et al. 1992) . Indeed, when the vitamin B 12 -sufficient rats were exposed to hypoxia for 6 weeks, the serum Epo concentration was significantly (P, 0·05) greater, compared with a normoxic level, in early phase (on day 1), but it was normalized in 1 week after starting the exposure. These results indicate that the vitamin B 12 -sufficient rats are able to adapt to hypoxia in 1 week by increasing the ERC count. However, in the deficient rats, the Epo concentration did not return to a normal level (normoxic level) even after the 6-week exposure to hypoxia. It is thus suggested that O 2 is not provided into tissues at an adequate level in the vitamin B 12 -deficient rats, in contrast to the -sufficient controls, throughout the exposure to hypoxia for 6 weeks.
Results obtained in the present paper show that the hypoxia-induced erythropoiesis is affected in rats when the plasma vitamin B 12 concentration is lowered to , 15 % of a normal level, although haematological abnormalities with anaemia are not observed under normoxic conditions. Consequently, megaloblastic anaemialike symptoms appear when these vitamin B 12 -deficient rats are exposed to low O 2 conditions. This is the first report showing a way in which a rat model can be used to study megaloblastic changes associated with vitamin B 12 deficiency.
